Human trials for an experimental Zika vaccine are about to start in the US
The trial will last two years
1/cdn0.vox-cdn.com/uploads/chorus_image/image/50285889/vaccine-main-use.0.png)
As the identified four cases of the Zika virus that were likely transmitted by mosquitoes, which will make efforts to combat the illness even more difficult.
The first human trials for the vaccine will take place in Maryland and Georgia, according to DNA vaccine was proven to be effective in mice.
The vaccine in question is called a DNA Vaccine, a third-generation vaccine that contains some specific antigens from the disease in question. The host body will pick up the DNA from the pathogen and begin to formulate an immune response. This type of vaccine is different from others, which utilize weakened or dead germs to stimulate a response (such as for polio or smallpox) or a subunit of a pathogen.
Currently, no third generation vaccines are approved for human use in the US
Currently, there aren’t any such vaccines that can be used on people in the United States, although Australia permits the use of one for Japanese encephalitis, another mosquito-borne illness. According to the National Institutes of Health, this Zika vaccine is similar to another third-generation vaccine trial that had been developed for the West Nile Virus, which was demonstrated to be safe.
There are other vaccines on the way: experimental trial from Inovio Pharmaceuticals was adverse affects.
- ViaTechnology Review
- SourceNIH
More from The Verge
- Welcome to AirSpace
- Mossberg: TVs are still too complicated, and it's not your fault
- China finally built an elevated bus that straddles traffic and it's totally bizarre
- Samsung Galaxy Note 7 arrives August 19th with curved display, iris scanner
- Moon Express becomes first private company to get US approval for lunar mission
- Xbox One S review
- Suicide Squad review: too many villains, not enough real villainy